drugset / Trial / NCT04752384
Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients
NaSingle-groupOpen-labelSupportive care
Summary
This is a single-arm prospective clinical trial to determine the safety and feasibility of using transdermal buprenorphine in alleviation of radiation induced mucositis pain in head and neck cancer patients.
Timeline
- Start
- 2021-07-08
- Primary completion
- 2024-04-04
- Completion
- 2024-04-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | 20 ug | Other |
| Subject | Tramadol | Other / unclassified | 400 mg | Oral |